Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-16-096061

Options or other derivatives

  • SVP & Chief Medical Officer acquired 100,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Gergel Ivan P. · SVP & Chief Medical Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2016-02-03 Grant or award : show line 1 in the form Stock Option +100,000 $12.21 2024-02-02 100,000 100,000 D
Loading xslF345X03/doc4.xml…